JAHVEL THOMPSON: Open Payments
NPI 1134527096 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 14 payments from 10 companies in 2025. Trend: 2023 $270 · 2024 $236 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $85 |
| Novo Nordisk Inc | 2 | $38 |
| Exact Sciences Corporation | 2 | $36 |
| PFIZER INC. | 1 | $26 |
| Corcept Therapeutics | 1 | $26 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| Cipher Pharmaceuticals US LLC | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Cranial Technologies, Inc | 1 | $16 |
Products named: REZDIFFRA, Cologuard Collection Kit, PREVNAR 20, Korlym, TZIELD, JOURNAVX, Natroba, Ozempic.
Industry payments across TX — which companies pay providers there.
